EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

CDSCO Tightens Drug Quality: Outsourced Audits, 1,500 Experts, Tighter Safety Rules - India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is implementing one of the most ambitious regulatory overhauls in its history. In a series of coordinated actions between February and June 2026, CDSCO has announced plans to outsource Good Manufacturing Practices (GMP) audits to certified third-party agencies, build a 1,500-strong scientific cadre, tightened safety […]
India Pharma 2026 Highlights 7.7% Growth and Global Pharma Push - The 9th edition of India Pharma 2026, the flagship event of the Department of Pharmaceuticals under India’s Ministry of Chemicals and Fertilizers, has spotlighted India’s growing influence in the global pharmaceutical landscape. With Union Minister JP Nadda declaring India “well positioned to emerge as a global leader in pharma” and Commerce Minister Piyush Goyal reporting […]
India’s Semaglutide Generic Boom Reshapes GLP-1 Market in 2026 - On March 20, 2026, Novo Nordisk’s patent on semaglutide expired in India, triggering one of the most significant transformations in the country’s pharmaceutical history. Within weeks, more than 40 Indian generic drugmakers launched approximately 50 branded generic versions of the active ingredient found in Ozempic® and Wegovy®, fundamentally reshaping access to GLP-1 receptor agonist therapies […]
CDSCO 2026 Overhaul: GMP Audits Outsourced, 1,500 Experts Hired as India Tightens Pharma Quality Standards - The Central Drugs Standard Control Organization (CDSCO) is undertaking its most significant regulatory transformation in decades. In a series of reforms announced in early 2026, India’s drug regulator has unveiled plans to outsource Good Manufacturing Practices (GMP) audits to certified third-party agencies, build a 1,500-strong scientific cadre, and ease export No Objection Certificate (NOC) norms […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us